SB
Sutro Biopharma
🇩🇪XFRA.S09GermanyHealthcare
€13.20EURup +1.10 (+9.09%)OpenEnd of day9:12 AM
Price€13.20+1.10 (+9.09%)
Profile
- Healthcare
- Biotechnology
- Germany
Identity
- Exchange
- Frankfurt Stock Exchange . XFRA
- Type
- Stock
- ISIN
- US8693671021
- CUSIP
- Not reported
Company
- Employees
- 128
- Headquarters
- South San Francisco, United States
- Website
- https://www.sutrobio.com
- CEO
- Ms. Jane Chung R.Ph.
Market
- Shares outstanding
- 85.1M
- Market cap
- €1.12B
Highlights
- Market cap
- €1.12B
- EPS LTM
- -$2.12calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- Not reported
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $45.7M-56.25%down year on year
- Net income
- -$180.64M+13.45%up year on year
- Gross margin
- 89.49%-8.8%down year on year
- Free cash flow
- -$145.62M+42.22%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.